NCT07476053 Light Exposure, Migraine Outcomes, and Sleep Quality
| NCT ID | NCT07476053 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Arizona State University |
| Condition | Migraine Headache |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2026-03-24 |
| Primary Completion | 2027-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2026-03-24 with a primary completion date of 2027-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to examine the relationship between daily light exposure patterns, sleep quality, and migraine characteristics in adults with migraine, with and without photophobia, across an 8-week study period.
Eligibility Criteria
Inclusion Criteria: * Meet the International Classification of Headache Disorders, 3rd edition (2018) criteria for migraine, with or without aura or photosensitivity * Report experiencing more than 4 headache days per month and at least three migraine attacks per month * No other major health issues based on self-reported data * Able to read and communicate in English * Work in a private office space for at least six hours per day, four days per week Exclusion Criteria: * Light therapy * Use light-altering devices (e.g., blue-blocking contact lenses or glasses) * Traveling out of town during the participation
Contact & Investigator
Nina Sharp, PhD
PRINCIPAL INVESTIGATOR
Arizona State University
Frequently Asked Questions
Who can join the NCT07476053 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Migraine Headache. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07476053 currently recruiting?
Yes, NCT07476053 is actively recruiting participants. Contact the research team at nina.sharp@asu.edu for enrollment information.
Where is the NCT07476053 trial being conducted?
This trial is being conducted at Tempe, United States.
Who is sponsoring the NCT07476053 clinical trial?
NCT07476053 is sponsored by Arizona State University. The principal investigator is Nina Sharp, PhD at Arizona State University. The trial plans to enroll 20 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.